Latent Tuberculosis in HIV positive, diagnosed by the M. Tuberculosis Specific Interferon-γ test
Top Cited Papers
Open Access
- 1 April 2006
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 7 (1) , 56
- https://doi.org/10.1186/1465-9921-7-56
Abstract
Background: Although tuberculosis (TB) is a minor problem in Denmark, severe and complicated cases occur in HIV positive. Since the new M. tuberculosis specific test for latent TB, the QuantiFERON-TB In-Tube test (QFT-IT) became available the patients in our clinic have been screened for the presence of latent TB using the QFT-IT test. We here report the results from the first patients screened. Methods: On a routine basis the QFT-IT test was performed and the results from 590 HIV positive individuals consecutively tested are presented here. CD4 cell count and TB risk-factors were recorded from patient files. Main findings: 27/590(4.6%) of the individuals were QFT-IT test positive, indicating the presence of latent TB infection. Among QFT-IT positive patients, 78% had risk factors such as long-term residency in a TB high endemic area (OR:5.7), known TB exposure (OR:4.9) or previous TB disease (OR:4.9). The prevalence of latent TB in these groups were 13%, 16% and 19% respectively. There was a strong correlation between low CD4 T-cell count and a low mitogen response (P < 0.001;Spearman) and more patients with low CD4 cell count had indeterminate results. Conclusion: We found an overall prevalence of latent TB infection of 4.6% among the HIV positive individuals and a much higher prevalence of latent infection among those with a history of exposure (16%) and long term residency in a high endemic country (13%). The QFT-IT test may indeed be a useful test for HIV positive individuals, but in severely immunocompromised, the test may be impaired by T-cell anergy.Keywords
This publication has 29 references indexed in Scilit:
- Enzyme-Linked Immunospot Assay Responses to Early Secretory Antigenic Target 6, Culture Filtrate Protein 10, and Purified Protein Derivative among Children with Tuberculosis: Implications for Diagnosis and Monitoring of TherapyClinical Infectious Diseases, 2005
- Demographics of HIV-1 infection in Denmark: Results from the Danish HIV Cohort StudyScandinavian Journal of Infectious Diseases, 2005
- Prospective Evaluation of a Whole-Blood Test Using Mycobacterium tuberculosis -Specific Antigens ESAT-6 and CFP-10 for Diagnosis of Active TuberculosisClinical and Vaccine Immunology, 2005
- Selected Pool of Peptides from ESAT-6 and CFP-10 Proteins for Detection of Mycobacterium tuberculosis InfectionJournal of Clinical Microbiology, 2004
- Detection of latent tuberculosis among HIV-infected patients after initiation of highly active antiretroviral therapyAIDS, 2003
- The potential of recombinant antigens ESAT-6, MPT63 and mig for specific discrimination of Mycobacterium tuberculosis and M. avium infectionEuropean Journal of Pediatrics, 2003
- Long‐Lived Immune Response to Early Secretory Antigenic Target 6 in Individuals Who Had Recovered from TuberculosisClinical Infectious Diseases, 2001
- Underestimation of Mycobacterium tuberculosis infection in HIV-infected subjects using reactivity to tuberculin and anergy panelInternational Journal of Epidemiology, 2000
- Epidemiology of Tuberculosis in HIV-infected Patients in DenmarkScandinavian Journal of Infectious Diseases, 1999
- Comparison of a Tuberculin Interferon‐γ Assay with the Tuberculin Skin Test in High‐Risk Adults: Effect of Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 1997